Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/de/projects/888-mk-7902-005-a-multicenter-open-label-phase-2-study-of-lenvatinib-e7080mk-7902-plus-pembrolizumab-mk-3475-in-previously-treated-subjects-with-selected-solid-tumors-leap-005